
Veeva Systems (VEEV) Stock Forecast & Price Target
Veeva Systems (VEEV) Analyst Ratings
Bulls say
Veeva Systems experienced a significant increase in net headcount, reflecting strategic growth and investment in talent necessary for driving innovation and service expansion, with notable advancements in its R&D and Quality Cloud offerings. The company reported a strong fourth quarter performance, highlighted by robust subscription revenue, exceptional results from Crossix, and an impressive professional services revenue of $16 million, driven primarily by Business Consulting. Veeva's solid financial outlook for FY27, featuring a 12.4% year-over-year implied top-line growth and a 44.3% operating margin, underscores its continued strong market position and potential for further share gains within the life sciences sector.
Bears say
Veeva Systems has experienced a slight compression in its operating margin to 44% for Q4, alongside a year-over-year decline in margins attributed to a shift toward services and the timing of new hires for upcoming projects. Subscription revenue growth has slowed to 16% year-over-year, indicating potential headwinds from competitive pressures in the pharma CRM space and a lack of adoption for new product offerings. Furthermore, normalized billings guidance of 10-11% reflects a significant decrease from recent trends, suggesting a lower growth outlook that contributes to a more cautious financial perspective on the company's future.
This aggregate rating is based on analysts' research of Veeva Systems and is not a guaranteed prediction by Public.com or investment advice.
Veeva Systems (VEEV) Analyst Forecast & Price Prediction
Start investing in Veeva Systems (VEEV)
Order type
Buy in
Order amount
Est. shares
0 shares